SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Healthpeak Properties, Inc. (PEAK) trades at a trailing P/E of 171.0. Trailing earnings yield is 0.58%.
Criteria proven by this page:
- VALUE (62/100, Pass) — analyst target implies upside (+80.2%).
- Trailing Earnings Yield 0.58% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
- Analyst consensus target $30.82 (+80.2% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 68/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
62/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PEAK
Valuation Multiples
P/E (TTM)171.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio4.22
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.10
Book Value / Share$0.00
Revenue / Share$4.06
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.58%
Dividend Yield0.00%
Analyst Target$30.82 (+80.2%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.22 |
$241.03M |
$29.98M |
12.4% |
| 2017 |
$0.23 |
$343.58M |
$38.15M |
11.1% |
| 2018 |
$0.30 |
$422.55M |
$56.23M |
13.3% |
| 2019 |
$0.02 |
$415.28M |
$9.49M |
2.3% |
| 2020 |
$0.02 |
$437.51M |
$10.2M |
2.3% |
| 2021 |
$0.05 |
$457.7M |
$25.4M |
5.5% |
| 2022 |
$0.07 |
$526.64M |
$37.8M |
7.2% |
| 2023 |
$0.56 |
$2.18B |
$306.01M |
14% |
| 2024 |
$0.36 |
$2.7B |
$243.14M |
9% |
| 2025 |
$0.10 |
$2.82B |
$293.58M |
10.4% |
